MICAFUNGIN SODIUM FOR INJECTION DIN 02547228
Status: Marketed
Holder: JUNO PHARMA CANADA INC.
Molecule: MICAFUNGIN (MICAFUNGIN SODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J02AX05 MICAFUNGIN |
| Original market date | 12-Dec-2024 |
| Current status date | 27-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Juno Pharma Canada Inc. — licence 3-002916, currently licensed, last inspection rating C (2025-11-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MICAFUNGIN (MICAFUNGIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02543176 | MICAFUNGIN FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Approved |
| 02543168 | MICAFUNGIN FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Approved |
| 02560488 | MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION | BAXTER CORPORATION | Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Approved |
| 02560496 | MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION | BAXTER CORPORATION | Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Approved |
| 02560518 | MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION | BAXTER CORPORATION | Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 150 MG | Approved |
| 02547236 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMA CANADA INC. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Marketed |
| 02524961 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Marketed |
| 02524953 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38010 | 2026-07-27 | Abbreviated New Drug Submission (ANDS) | Administrative: Merger/Buy-out |
| 33120 | 2024-04-25 | Abbreviated New Drug Submission (ANDS) |